GHRP-6 in Research: Ghrelin-Receptor Signaling and Documentation Context
A research-use overview of GHRP-6, its growth-hormone secretagogue literature, receptor context, analytical handling, and documentation expectations.
Read moreResearch articles
Research articles
Since 2019, ADRIA has built a research-use-only article archive covering peptide literature, analytical documentation, storage, laboratory workflow, and evidence limits. The archive is organized by topic so researchers can move from source review to COA, calculator, and catalogue context quickly.
Quality Claims Need Evidence: Batch Documentation, COA Review, and Testing Context
A clear Adria statement on why quality claims should be tied to batch records, COA review, analytical methods, and traceable supplier documentation.
Read more
Research Peptide Quality: COA Transparency, HPLC Context, and Batch Traceability
A documentation-first view of research peptide quality, focusing on COA traceability, analytical methods, and why unsupported purity claims are not enough.
Read more
Thymosin Alpha 1 in Research: Immune Signaling Literature and Documentation Context
A balanced Thymosin Alpha 1 overview using review literature while avoiding cancer, infection, or immune-outcome claims on the Adria blog.
Read more
Peptide Synthesis in Research Labs: SPPS, Purification, and COA Documentation
A technical Adria research note on solid-phase peptide synthesis, Fmoc-SPPS, purification, lyophilization, and why batch documentation matters.
Read more
Pyk2-PRR2 Peptide Research: Invadopodia Models and Metastasis Biology
A rebuilt article on the Bar-Ilan Pyk2-PRR2 peptide study, focused on invadopodia biology, cortactin interaction, and preclinical evidence limits.
Read more
Peptide Research Evidence Map: From Mechanism Papers to Batch Documentation
A broad peptide research article reframed around evidence tiers, peptide characterization, delivery constraints, and why documentation matters more than hype.
Read more
COVID-19 Study Methodology: Monitored Parameters, T-Cell Markers, and Evidence Limits
A method-focused rewrite about monitored parameters in COVID-19 Thymosin Alpha 1 studies, emphasizing endpoints and limits rather than intervention claims.
Read more
Peptides and Soft-Tissue Models: Tendon, Cornea, Matrix, and Evidence Limits
A research-use-only soft-tissue article focused on Thymosin Beta 4, BPC-157, matrix signaling, angiogenesis markers, and preclinical research limits.
Read more